Pricing Log in Create free account

Acrivon Therapeutics, Inc. (ACRV) vs Nordicus Partners Corporation (NORD)

Acrivon Therapeutics, Inc. and Nordicus Partners Corporation are both Biotechnology companies. Acrivon Therapeutics, Inc. and Nordicus Partners Corporation are of similar size ($74.6M and $72.4M). Across the 10 metrics below, Nordicus Partners Corporation leads on 7 and Acrivon Therapeutics, Inc. on 3.

Valuation

Metric ACRV NORD Biotechnology median
P/E n/m n/m 10.26
P/S n/m 81.31 9.18
P/B 0.76 1.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.31 n/m 0.65
EV/Sales n/m 83.80 8.98
Earnings yield (118.99%) (8.24%) (34.89%)
Free cash flow yield (97.02%) (6.25%) (24.52%)

Profitability

Metric ACRV NORD Biotechnology median
Gross margin 0.00% 70.18% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (64.63%) (8.06%) (50.12%)
Return on assets (57.61%) (6.80%) (45.60%)
Return on invested capital 0.00% (4.43%) 0.00%

Growth

Metric ACRV NORD Biotechnology median
Revenue growth (TTM) — (71.68%) 6.26%
EPS growth (last fiscal year) 15.13% 30.58% 29.88%
Revenue growth, 5-year CAGR — (71.31%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACRV NORD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.99 0.18 4.89
Net debt to EBITDA 1.43 0.00 1.01

Dividend

Metric ACRV NORD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACRV NORD Biotechnology median
Market cap 74.57m 72.43m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack